Titanium Media App reported on August 23 that the World Health Organization (WHO) announced that China has passed the assessment of the National Regulatory System (NRA) for vaccines. The WHO's assessment of the national vaccine regulatory system is an important measure and an effective means of assessing the national vaccine regulatory capacity. my country's vaccine regulatory system has passed the evaluation twice in 2011 and 2014, and in July 2022, it will usher in a new round of comprehensive evaluation after the WHO's upgraded evaluation standards. The evaluation indicators have been greatly increased, the content is more comprehensive, and the standards are more stringent. Through the evaluation, it not only means that China has a stable, well-functioning and complete and unified supervision system, it can ensure that the quality of vaccines produced, imported or circulated in China is controllable, safe and effective, and it is also an important basis for my country's vaccine exports to the world. WHO will pass the evaluation of the vaccine regulatory system as a precondition for purchasing vaccine products from the country, that is, only after the national regulatory system has passed the evaluation, the country's enterprises can apply for WHO pre-certification of vaccine products and include them in the procurement list of international organizations such as the United Nations. In addition, passing the evaluation is also an important reference for other countries to register and purchase vaccine products from other countries.
media coverage
Titanium Media 36Kr
Related events
- China’s vaccine supervision system passed the new round of evaluation by the World Health Organization2022-08-23
- Multi-country real-world data confirms that vaccines can reduce mortality by the highest or even dozens of times 2022-01-21
This article is reproduced from: https://readhub.cn/topic/8iIFMcBe64k
This site is for inclusion only, and the copyright belongs to the original author.